We are live on ! Find out more
SCA

SAC Capital Advisors Portfolio holdings

AUM $19.3B
1-Year Est. Return 31.93%
This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+31.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.2B
AUM Growth
Cap. Flow
+$18.1B
Cap. Flow %
99.41%
Top 10 Hldgs %
13.35%
Holding
1,626
New
1,625
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$243M
2
SLB icon
SLB Ltd
SLB
+$215M
3
AMZN icon
Amazon
AMZN
+$198M
4
MU icon
Micron Technology
MU
+$180M
5
EOG icon
EOG Resources
EOG
+$179M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.48%
2 Energy 11.89%
3 Healthcare 9.2%
4 Technology 8.95%
5 Communication Services 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEDL
1526
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$125K ﹤0.01%
+12,819
New +$139K
GPI icon
1527
Group 1 Automotive
GPI
$4.26B
$123K ﹤0.01%
+1,918
New +$119K
RUTH
1528
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$123K ﹤0.01%
+10,181
New +$111K
AMAG
1529
DELISTED
AMAG Pharmaceuticals
AMAG
$123K ﹤0.01%
+5,519
New +$122K
NFBK
1530
DELISTED
Northfield Bancorp
NFBK
$120K ﹤0.01%
+10,223
New +$118K
RIGL icon
1531
Rigel Pharmaceuticals
RIGL
$723M
$114K ﹤0.01%
+3,420
New +$155K
AKS
1532
DELISTED
AK Steel Holding Corp
AKS
$113K ﹤0.01%
+37,307
New +$123K
CADX
1533
DELISTED
CADENCE PHARMACEUTICALS, INC COM STK
CADX
$112K ﹤0.01%
+16,477
New +$115K
NVMI
1534
Nova
NVMI
$11.7B
$111K ﹤0.01%
+12,228
New +$112K
IRWD icon
1535
Ironwood Pharmaceuticals
IRWD
$586M
$110K ﹤0.01%
+13,188
New +$160K
TRQ
1536
DELISTED
Turquoise Hill Resources Ltd
TRQ
$110K ﹤0.01%
+2,413
New +$121K
AXLL
1537
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$110K ﹤0.01%
+2,590
New +$127K
DXLG icon
1538
Destination XL Group
DXLG
$32.9M
$109K ﹤0.01%
+17,131
New +$89.7K
PSEM
1539
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
$109K ﹤0.01%
+15,350
New +$105K
MWIV
1540
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$109K ﹤0.01%
+883
New +$108K
SGNT
1541
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$108K ﹤0.01%
+5,136
New +$91.8K
JRN
1542
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
$108K ﹤0.01%
+14,430
New +$98.2K
FBP icon
1543
First Bancorp
FBP
$4.41B
$107K ﹤0.01%
+15,070
New +$94K
UAM
1544
DELISTED
Universal American Corp
UAM
$106K ﹤0.01%
+11,926
New +$108K
VG
1545
DELISTED
Vonage Holdings Corporation
VG
$106K ﹤0.01%
+37,452
New +$106K
AMD icon
1546
Advanced Micro Devices
AMD
$700B
$103K ﹤0.01%
+25,343
New +$87.6K
LSCC icon
1547
Lattice Semiconductor
LSCC
$16B
$103K ﹤0.01%
+20,373
New +$102K
HOV icon
1548
Hovnanian Enterprises
HOV
$779M
$101K ﹤0.01%
+722
New +$104K
ING icon
1549
ING
ING
$92.9B
$101K ﹤0.01%
+11,066
New +$94.6K
ARNA
1550
DELISTED
Arena Pharmaceuticals Inc
ARNA
$101K ﹤0.01%
+1,310
New +$107K

Similar funds

SAC Capital Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for SAC Capital Advisors, which disclosed 1,626 positions worth $18.2B. Its ten largest holdings account for 13% of the portfolio.

Its largest position is Zoetis: 7,509,206 shares worth $232M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, followed by Energy and Healthcare.

  • SAC Capital Advisors's largest Q2 2013 buy was Zoetis: 7,509,206 shares worth $232M.
  • SAC Capital Advisors's ten largest holdings make up 13% of its $18.2B portfolio in Q2 2013.
  • SAC Capital Advisors disclosed 1,626 positions in Q2 2013, its first 13F filing on record.

Based on SAC Capital Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.